Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Structural and Functional Characterization of an Electron Transfer Flavoprotein Involved in Toluene Degradation in Strictly Anaerobic Bacteria.

Vogt MS, Schühle K, Kölzer S, Peschke P, Chowdhury NP, Kleinsorge D, Buckel W, Essen LO, Heider J.

J Bacteriol. 2019 Oct 4;201(21). pii: e00326-19. doi: 10.1128/JB.00326-19. Print 2019 Nov 1.

PMID:
31405915
2.

Examining correlations of oxygen sensitive MRI (BOLD/TOLD) with [18F]FMISO PET in rat prostate tumors.

Zhou H, Chiguru S, Hallac RR, Yang D, Hao G, Peschke P, Mason RP.

Am J Nucl Med Mol Imaging. 2019 Apr 15;9(2):156-167. eCollection 2019.

3.

Intrinsic and extrinsic tumor characteristics are of minor relevance for the efficacy of split-dose carbon ion irradiation in three experimental prostate tumors.

Glowa C, Peschke P, Brons S, Debus J, Karger CP.

Radiother Oncol. 2019 Apr;133:120-124. doi: 10.1016/j.radonc.2018.12.017. Epub 2019 Jan 24.

PMID:
30935567
4.

Mechanically metastable structures generated by single pulse laser-induced periodic surface structures (LIPSS) in the photoresist SU8.

Reinhardt H, Peschke P, Riedel R, Hampp N.

Nanotechnology. 2018 Jul 27;29(30):305303. doi: 10.1088/1361-6528/aac378. Epub 2018 May 9.

PMID:
29742067
5.

Determination of the proton RBE in the rat spinal cord: Is there an increase towards the end of the spread-out Bragg peak?

Saager M, Peschke P, Brons S, Debus J, Karger CP.

Radiother Oncol. 2018 Jul;128(1):115-120. doi: 10.1016/j.radonc.2018.03.002. Epub 2018 Mar 21.

PMID:
29573823
6.

Late normal tissue response in the rat spinal cord after carbon ion irradiation.

Saager M, Peschke P, Welzel T, Huang L, Brons S, Grün R, Scholz M, Debus J, Karger CP.

Radiat Oncol. 2018 Jan 11;13(1):5. doi: 10.1186/s13014-017-0950-5.

7.

Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.

Glowa C, Peschke P, Brons S, Neels OC, Kopka K, Debus J, Karger CP.

Radiat Oncol. 2017 Nov 9;12(1):174. doi: 10.1186/s13014-017-0914-9.

8.

RBE and related modeling in carbon-ion therapy.

Karger CP, Peschke P.

Phys Med Biol. 2017 Dec 19;63(1):01TR02. doi: 10.1088/1361-6560/aa9102. Review.

PMID:
28976361
9.

Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis.

Bickelhaupt S, Erbel C, Timke C, Wirkner U, Dadrich M, Flechsig P, Tietz A, Pföhler J, Gross W, Peschke P, Hoeltgen L, Katus HA, Gröne HJ, Nicolay NH, Saffrich R, Debus J, Sternlicht MD, Seeley TW, Lipson KE, Huber PE.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw339.

PMID:
28376190
10.

The relative biological effectiveness of carbon ion irradiations of the rat spinal cord increases linearly with LET up to 99 keV/μm.

Saager M, Glowa C, Peschke P, Brons S, Grün R, Scholz M, Huber PE, Debus J, Karger CP.

Acta Oncol. 2016 Dec;55(12):1512-1515. Epub 2016 Nov 9. No abstract available.

PMID:
27827542
11.

Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.

White DA, Zhang Z, Li L, Gerberich J, Stojadinovic S, Peschke P, Mason RP.

Cancer Lett. 2016 Sep 28;380(1):69-77. doi: 10.1016/j.canlet.2016.06.003. Epub 2016 Jun 3.

12.

Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors.

Glowa C, Karger CP, Brons S, Zhao D, Mason RP, Huber PE, Debus J, Peschke P.

Cancer Lett. 2016 Aug 10;378(2):97-103. doi: 10.1016/j.canlet.2016.05.013. Epub 2016 May 17.

PMID:
27224892
13.

A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response.

Hallac RR, Zhou H, Pidikiti R, Song K, Solberg T, Kodibagkar VD, Peschke P, Mason RP.

Br J Cancer. 2016 May 24;114(11):1206-11. doi: 10.1038/bjc.2016.110. Epub 2016 May 3.

14.

Static FET-PET and MR Imaging in Anaplastic Gliomas (WHO III).

Bette S, Peschke P, Kaesmacher J, Delbridge C, Pyka T, Schmidt-Graf F, Zimmer C, Meyer B, Ringel F, Gempt J.

World Neurosurg. 2016 Jul;91:524-531.e1. doi: 10.1016/j.wneu.2016.02.094. Epub 2016 Mar 4.

PMID:
26947726
15.

Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.

Mena-Romano P, Cheng C, Glowa C, Peschke P, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A, Karger CP.

Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):348-62. eCollection 2015.

16.

Split dose carbon ion irradiation of the rat spinal cord: Dependence of the relative biological effectiveness on dose and linear energy transfer.

Saager M, Glowa C, Peschke P, Brons S, Grün R, Scholz M, Huber PE, Debus J, Karger CP.

Radiother Oncol. 2015 Nov;117(2):358-63. doi: 10.1016/j.radonc.2015.07.006. Epub 2015 Jul 18.

PMID:
26197953
17.

Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenation.

Zhao D, Pacheco-Torres J, Hallac RR, White D, Peschke P, Cerdán S, Mason RP.

NMR Biomed. 2015 Aug;28(8):937-947. doi: 10.1002/nbm.3325. Epub 2015 Jun 8.

18.

18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.

Gempt J, Bette S, Ryang YM, Buchmann N, Peschke P, Pyka T, Wester HJ, Förster S, Meyer B, Ringel F.

Eur J Radiol. 2015 May;84(5):955-62. doi: 10.1016/j.ejrad.2015.01.022. Epub 2015 Feb 7.

PMID:
25748815
19.

A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.

Espinoza I, Peschke P, Karger CP.

Med Phys. 2015 Jan;42(1):90-102. doi: 10.1118/1.4903298.

PMID:
25563250
20.

Carbon ion irradiation of the rat spinal cord: dependence of the relative biological effectiveness on linear energy transfer.

Saager M, Glowa C, Peschke P, Brons S, Scholz M, Huber PE, Debus J, Karger CP.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):63-70. doi: 10.1016/j.ijrobp.2014.05.008. Epub 2014 Jul 3.

PMID:
24998894
21.

Photon and carbon ion irradiation of a rat prostate carcinoma: does a higher fraction number increase the metastatic rate?

Karger CP, Scholz M, Huber PE, Debus J, Peschke P.

Radiat Res. 2014 Jun;181(6):623-8. doi: 10.1667/RR13611.1. Epub 2014 May 20.

PMID:
24844648
22.

A model to simulate the oxygen distribution in hypoxic tumors for different vascular architectures.

Espinoza I, Peschke P, Karger CP.

Med Phys. 2013 Aug;40(8):081703. doi: 10.1118/1.4812431.

PMID:
23927300
23.

Flow cytometric characterization of tumor subpopulations in three sublines of the Dunning R3327 rat prostate tumor model.

Glowa C, Peschke P, Karger CP, Hahn EW, Huber PE, Debus J, Ehemann V.

Prostate. 2013 Nov;73(15):1710-20. doi: 10.1002/pros.22710. Epub 2013 Jul 12.

PMID:
23853045
24.

Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response.

Hallac RR, Zhou H, Pidikiti R, Song K, Stojadinovic S, Zhao D, Solberg T, Peschke P, Mason RP.

Magn Reson Med. 2014 May;71(5):1863-73. doi: 10.1002/mrm.24846. Epub 2013 Jun 27.

25.

Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.

Zwicker F, Kirsner A, Peschke P, Roeder F, Debus J, Huber PE, Weber KJ.

Strahlenther Onkol. 2013 Aug;189(8):684-92. doi: 10.1007/s00066-013-0354-x. Epub 2013 Jun 23.

PMID:
23793865
26.

Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions.

Karger CP, Peschke P, Scholz M, Huber PE, Debus J.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):450-5. doi: 10.1016/j.ijrobp.2013.01.019. Epub 2013 Mar 6.

PMID:
23474116
27.

A noninvasive tumor oxygenation imaging strategy using magnetic resonance imaging of endogenous blood and tissue water.

Zhang Z, Hallac RR, Peschke P, Mason RP.

Magn Reson Med. 2014 Feb;71(2):561-9. doi: 10.1002/mrm.24691.

28.

LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals.

Flechsig P, Dadrich M, Bickelhaupt S, Jenne J, Hauser K, Timke C, Peschke P, Hahn EW, Gröne HJ, Yingling J, Lahn M, Wirkner U, Huber PE.

Clin Cancer Res. 2012 Jul 1;18(13):3616-27. doi: 10.1158/1078-0432.CCR-11-2855. Epub 2012 Apr 30.

29.

Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.

Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.

Cancer Res. 2011 Dec 1;71(23):7155-67. doi: 10.1158/0008-5472.CAN-11-1212. Epub 2011 Oct 17.

30.

Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.

Zhang M, Herion TW, Timke C, Han N, Hauser K, Weber KJ, Peschke P, Wirkner U, Lahn M, Huber PE.

Neoplasia. 2011 Jun;13(6):537-49.

31.

HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F.

Nanomedicine (Lond). 2010 Dec;5(10):1501-23. doi: 10.2217/nnm.10.130.

PMID:
21143030
32.

Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat.

Peschke P, Karger CP, Scholz M, Debus J, Huber PE.

Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):239-46. doi: 10.1016/j.ijrobp.2010.07.1976. Epub 2010 Oct 8.

PMID:
20934276
33.

Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model.

Harting C, Peschke P, Karger CP.

Acta Oncol. 2010 Nov;49(8):1354-62. doi: 10.3109/0284186X.2010.485208. Epub 2010 Sep 15.

PMID:
20843178
34.

Multimodality imaging of hypoxia in preclinical settings.

Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EW, Peschke P.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):259-80. Review.

35.

Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions.

Palmowski M, Peschke P, Huppert J, Hauff P, Reinhardt M, Maurer M, Karger CP, Scholz M, Semmler W, Huber PE, Kiessling FM.

Neoplasia. 2009 Sep;11(9):856-63.

36.

Comparison of biological effectiveness of carbon-ion beams in Japan and Germany.

Uzawa A, Ando K, Koike S, Furusawa Y, Matsumoto Y, Takai N, Hirayama R, Watanabe M, Scholz M, Elsässer T, Peschke P.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1545-51. doi: 10.1016/j.ijrobp.2008.12.021.

PMID:
19306751
37.

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G.

Biomaterials. 2009 Jul;30(20):3466-75. doi: 10.1016/j.biomaterials.2009.02.040. Epub 2009 Mar 21.

PMID:
19304320
38.

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.

Lammers T, Subr V, Peschke P, Kühnlein R, Hennink WE, Ulbrich K, Kiessling F, Heilmann M, Debus J, Huber PE, Storm G.

Br J Cancer. 2008 Sep 16;99(6):900-10. doi: 10.1038/sj.bjc.6604561.

39.

Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms.

Junco JA, Basalto R, Fuentes F, Bover E, Reyes O, Pimentel E, Calzada L, Castro MD, Arteaga N, López Y, Hernández H, Bringas R, Garay H, Peschke P, Bertot J, Guillén G.

Adv Exp Med Biol. 2008;617:581-7. doi: 10.1007/978-0-387-69080-3_60.

PMID:
18497085
40.

What is the clinically relevant relative biologic effectiveness? A warning for fractionated treatments with high linear energy transfer radiation: in regard to Daşu and Toma-DAşu. (Int J Radiat Oncol Biol Phys 2008;70:867-874).

Karger CP, Jäkel O, Scholz M, Peschke P, Debus J.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1614; author reply 1614-5. doi: 10.1016/j.ijrobp.2007.12.032. No abstract available.

PMID:
18374234
41.

Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.

Junco JA, Peschke P, Zuna I, Ehemann V, Fuentes F, Bover E, Pimentel E, Basulto R, Reyes O, Calzada L, Castro MD, Arteaga N, López Y, Garay H, Hernández H, Bringas R, Guillén GE.

Vaccine. 2007 Dec 5;25(50):8460-8. Epub 2007 Oct 4.

PMID:
18022737
42.

Retrospective motion gating in small animal CT of mice and rats.

Bartling SH, Stiller W, Grasruck M, Schmidt B, Peschke P, Semmler W, Kiessling F.

Invest Radiol. 2007 Oct;42(10):704-14.

PMID:
17984768
43.

Role of PP2Calpha in cell growth, in radio- and chemosensitivity, and in tumorigenicity.

Lammers T, Peschke P, Ehemann V, Debus J, Slobodin B, Lavi S, Huber P.

Mol Cancer. 2007 Oct 17;6:65.

44.

Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.

Harting C, Peschke P, Borkenstein K, Karger CP.

Phys Med Biol. 2007 Aug 21;52(16):4775-89. Epub 2007 Jul 24.

PMID:
17671335
45.

Transcriptional network governing the angiogenic switch in human pancreatic cancer.

Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12890-5. Epub 2007 Jul 24.

46.

Biological intercomparison using gut crypt survivals for proton and carbon-ion beams.

Uzawa A, Ando K, Furusawa Y, Kagiya G, Fuji H, Hata M, Sakae T, Terunuma T, Scholz M, Ritter S, Peschke P.

J Radiat Res. 2007;48 Suppl A:A75-80.

47.

Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.

Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, Bachert P, Peschke P, Kirsch S, Kauczor HU, Delorme S, Semmler W, Kiessling F.

Neoplasia. 2007 Jan;9(1):57-67.

48.

Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.

Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Debus J, Huber P, Hennink W, Storm G.

J Control Release. 2007 Feb 26;117(3):333-41. Epub 2006 Nov 25.

PMID:
17215057
49.

Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications.

Karger CP, Peschke P, Sanchez-Brandelik R, Scholz M, Debus J.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1488-97.

PMID:
17126208
50.

Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.

Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Huber P, Hennink W, Storm G.

Neoplasia. 2006 Oct;8(10):788-95.

Supplemental Content

Loading ...
Support Center